Clinical Trial Update: Treatment of Persistent Viremia (Virus in Blood) in Chronic Hepatitis B Subjects Already Receiving Adefovir Dipivoxil [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating treatment of persistent viremia in chronic hepatitis B patients already receiving adefovir dipivoxil.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Hepsera (adefovir dipivoxil)

Snippet

Sponsor: Gilead Sciences | Conditions: Chronic Hepatitis B | Phase 2 | Status: COMPLETED | Results posted: 2009-07-07